Rothman Institute Orthopaedics
126
1
2
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.8%
1 terminated/withdrawn out of 126 trials
97.4%
+10.9% vs industry average
24%
30 trials in Phase 3/4
3%
1 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (126)
Dual Mobility Acetabular Cups in Revision TJA
Role: collaborator
Dual Mobility in "High Risk" Patients
Role: collaborator
Robotic Assisted TKA
Role: lead
Automated V Manual Impactor Study
Role: lead
Surgiphor Us in TSA
Role: lead
Exparel v Dexamethasone in RCR
Role: lead
Wound Drain After Lumbar Fusion Surgery
Role: lead
Pain Control After Lumbar Spine Fusion
Role: lead
Treatment of Tendinosis Using the TenJet Hydroresection System
Role: lead
Exparel vs Block for ACL Reconstruction
Role: lead
Liposomal Bupivacaine With Dexamethasone for Foot Surgery
Role: lead
Antibiotic Loaded Cement After TKA
Role: lead
Randomized Trial of Intraoperative IV Versus Preoperative Oral Acetaminophen During Ambulatory Lumbar Discectomy
Role: lead
Diagnosing Compartment Syndrome With SHAPE vs Elastography
Role: collaborator
Effect of Mindfulness on Pain After Total Knee Arthroplasty
Role: lead
Post Operative Pain Management for ACL Reconstruction
Role: lead
The Use of Barbed Sutures in Total Hip Arthroplasty
Role: lead
Wound Healing in Primary TKA
Role: lead
Hip DAA Closure Techniques
Role: lead
Fusion Status After ACDF
Role: lead